Alterity Therapeutics Limited (ATH.AX) - Stock Prices, Stock Peers & Analysis

Home
ATH.AX

Company Name	Alterity Therapeutics Limited
Symbol	ATH.AX
Currency	AUD
Price	0.003
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	18,621,176
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.003 - 0.009
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Geoffrey Paul Kempler B.Sc, B.Sc.
Website	https://alteritytherapeutics.com

An error occurred while fetching data.

About Alterity Therapeutics Limited

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing